Foster James D, Adkins Steven D, Lever John R, Vaughan Roxanne A
Department of Biochemistry and Molecular Biology, University of North Dakota School of Medicine and Health Sciences, North Dakota 58202, USA.
J Neurochem. 2008 Jun;105(5):1683-99. doi: 10.1111/j.1471-4159.2008.05262.x. Epub 2008 Feb 1.
We examined the mechanisms involved in protein kinase C (PKC)-dependent down-regulation of dopamine transporter (DAT) activity and cell surface expression by treating heterologously expressing cells with the clathrin-mediated endocytosis inhibitor concanavalin A (Con A) or the cholesterol depleter/membrane raft disrupter methyl-beta-cyclodextrin (MbetaC) prior to treatment with the PKC activator phorbol 12-myristate, 13-acetate (PMA). Con A blocked PMA-induced surface reductions of DAT but only partially inhibited down-regulation, while MbetaC partially blocked down-regulation but did not inhibit loss of cell surface DAT, demonstrating that PKC-induced DAT down-regulation occurs by a combination of trafficking and non-trafficking processes. Using density-gradient centrifugation, we found that DATs are distributed approximately equally between Triton-insoluble, cholesterol-rich membrane rafts and Triton-soluble non-raft membranes. DATs in both populations are present at the cell surface and are active for dopamine and cocaine binding. PMA-induced loss of cell surface DAT occurred only from non-raft populations, demonstrating that non-raft DATs are regulated by trafficking events and indicating the likelihood that the cholesterol-dependent non-trafficking regulatory mechanism occurs in rafts. PMA did not affect the DAT raft-non-raft distribution but stimulated the phosphorylation of DAT to a substantially greater level in rafts than non-rafts. These findings reveal a previously unknown role for cholesterol in DAT function and demonstrate the presence of distinct subcellular DAT populations that possess multiple regulatory differences that may impact dopaminergic neurotransmission.
我们通过在用蛋白激酶C(PKC)激活剂佛波醇12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)处理之前,用网格蛋白介导的内吞作用抑制剂伴刀豆球蛋白A(Con A)或胆固醇耗竭剂/膜筏破坏剂甲基-β-环糊精(MβC)处理异源表达细胞,来研究参与PKC依赖性多巴胺转运体(DAT)活性下调和细胞表面表达的机制。Con A阻断了PMA诱导的DAT表面减少,但仅部分抑制下调,而MβC部分阻断下调,但不抑制细胞表面DAT的丢失,表明PKC诱导的DAT下调是通过转运和非转运过程的组合发生的。使用密度梯度离心,我们发现DATs在不溶于Triton的、富含胆固醇的膜筏和可溶于Triton的非筏膜之间大致均匀分布。这两个群体中的DATs都存在于细胞表面,并且对多巴胺和可卡因结合具有活性。PMA诱导的细胞表面DAT丢失仅发生在非筏群体中,表明非筏DATs受转运事件调节,并表明胆固醇依赖性非转运调节机制可能发生在膜筏中的可能性。PMA不影响DAT在筏和非筏之间的分布,但在筏中比在非筏中刺激DAT磷酸化至更高水平。这些发现揭示了胆固醇在DAT功能中以前未知的作用,并证明了存在具有多种调节差异的不同亚细胞DAT群体,这些差异可能影响多巴胺能神经传递。